Zacks.com on MSN5d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its ...
PMLiVE4d
GSK granted EC approval for meningococcal disease vaccine Menveo
GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...
GlobalData on MSN5d
EC approves GSK’s Menveo vaccine presentation for IMD
The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).
The Pharma Letter6d
EC nod for GSK’s Menveo meningococcal vaccine
The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...
GSK announces EC approved single-vial presentation of Menveo
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against ...
Daily4d
GSK fully liquid Menveo meningococcal vaccine approved by European Commission
London: GSK plc has announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of ...
GSK's liquid meningitis vaccine approved by EU regulators
GSK's liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process ...
Nasdaq5d
GSK Gets EC Nod for Liquid Version of Meningococcal Vaccine Menveo
GSK plc GSK announced that the European Commission (EC) has approved a single-vial, fully liquid presentation of its meningococcal vaccine, Menveo (MenACWY) for active immunization in children ...
Nasdaq6d
GSK announces EC approved single-vial presentation of Menveo
GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against invasive meningococcal disease, IMD, caused by ...